Evidence map›Paper›PMID 33661765›Full record

ArticleJCI insight2021

ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility.

Alexa K Pham, Marina Miller, Peter Rosenthal, Sudipta Das, Ning Weng, Sunghoon Jang, Richard C Kurten, Jana Badrani, Taylor A Doherty, Brian Oliver and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neutrophilia in severe asthma is reduced in Ormdl3 overexpressing mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  12. STIM1 is a core trigger of airway smooth muscle remodeling and hyperresponsiveness in asthma.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Alexa K PhamDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Marina MillerDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Peter RosenthalDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Sudipta DasDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Ning WengDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Sunghoon JangDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Richard C KurtenDepartment of Pediatrics, Arkansas Children's Research Institute, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Jana BadraniDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Taylor A DohertyDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Brian OliverSchool of Life Sciences, University of Technology Sydney, Sydney, Australia.
David H BroideDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
University of California San Diego · USUniversity of Technology Sydney · AUArkansas Children's Hospital · USUC San Diego Health System · US

Funding

TRM and airway inflammation and remodelingU19AI070535 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 2006 to 2025
$34.2M
TRAINING IN MOLECULAR &CELL BIOLOGY OF ALLERGYT32AI007469 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 1994 to 2024
$6.9M
Chromosome 17q, allergic inflammation, and remodelingR01AI107779 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 2013 to 2024
$4.7M
GSDMB and mucosal allergic responseR01AI124236 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 2017 to 2020
$2.4M
RBM3 regulation of type 2 innate lymphoid cells in allergic inflammationR01AI114585 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOHERTY, TAYLOR A · 2015 to 2019
$2.3M
Targeting pathogenic innate lymphoid cells in airway diseaseI01BX005073 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI TAYLOR A DOHERTY · 2021 to 2026
–
BLRD VA I01 BX005073NIAID NIH HHS R01 AI107779NIAID NIH HHS R01 AI114585NIAID NIH HHS R01 AI124236NIAID NIH HHS T32 AI007469NIAID NIH HHS U19 AI070535
6 · The paper itself

Abstract

ORM1-like 3 (ORMDL3) has strong genetic linkage to childhood onset asthma. To determine whether ORMDL3 selective expression in airway smooth muscle (ASM) influences ASM function, we used Cre-loxP techniques to generate transgenic mice (hORMDL3Myh11eGFP-cre), which express human ORMDL3 selectively in smooth muscle cells. In vitro studies of ASM cells isolated from the bronchi of hORMDL3Myh11eGFP-cre mice demonstrated that they developed hypertrophy (quantitated by FACS and image analysis), developed hyperplasia (assessed by BrdU incorporation), and expressed increased levels of tropomysin proteins TPM1 and TPM4. siRNA knockdown of TPM1 or TPM4 demonstrated their importance to ORMDL3-mediated ASM proliferation but not hypertrophy. In addition, ASM derived from hORMDL3Myh11eGFP-cre mice had increased contractility to histamine in vitro, which was associated with increased levels of intracellular Ca2+; increased cell surface membrane Orai1 Ca2+ channels, which mediate influx of Ca2+ into the cytoplasm; and increased expression of ASM contractile genes sarco/endoplasmic reticulum Ca2+ ATPase 2b and smooth muscle 22. In vivo studies of hORMDL3Myh11eGFP-cre mice demonstrated that they had a spontaneous increase in ASM and airway hyperreactivity (AHR). ORMDL3 expression in ASM thus induces changes in ASM (hypertrophy, hyperplasia, increased contractility), which may explain the contribution of ORMDL3 to the development of AHR in childhood onset asthma, which is highly linked to ORMDL3 on chromosome 17q12-21.

Indexed as

AnimalsAsthmaBronchial HyperreactivityCalciumCell ProliferationCells, CulturedHistamineHumansHyperplasiaHypertrophyMembrane ProteinsMice, TransgenicMuscle ContractionMuscle, SmoothSarcoplasmic Reticulum Calcium-Transporting ATPasesTropomyosinAtp2a2 protein, mouseCalciumHistamineMembrane ProteinsORMDL3 protein, humanSarcoplasmic Reticulum Calcium-Transporting ATPasesTpm1 protein, mouseTropomyosinAsthmaMuscle BiologyPulmonology

Identifiers

PMID33661765
PMCPMC8119187
OpenAlexW3134938910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.